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well. SheTo the editor
Transcranial direct current stimulation (tDCS) has attracted
considerable interest in recent years, especially as a potential inter-
vention in stroke rehabilitation and the treatment of depression.
Common safety guidelines exist to ensure the safety of the proced-
ure [1]. However, mild adverse effects (AEs) are common and more
severe AEs are occasionally encountered. Here, we report two cases
of skin lesions following tDCS.
Two females (aged 18 and 19 years) participated in experimental
tDCS studies focusing on cognition. A NeuroConn (Ilmenau, Ger-
many) stimulator was used. Stimulation was delivered using
carbon-rubber electrodes (5 7 cm2) fully enclosed inside conven-
tional reusable saline-soaked sponges. Nometal partswere exposed.
A 20-ml pod of saline was used for the two electrodes. The electrical
current was 1.5 mA for 15 min, with 16 seconds of fade-in and fade-
out. The same stimulator was used for all the stimulations, and the
output of the stimulatorwas veriﬁed after the stimulations. The sub-
jects rested their hands on a normal wooden ofﬁce desk. The anode
was placed over the left dorsolateral prefrontal cortex (F3 in the
10e20 international EEG electrode placement system) and the cath-
ode on the left wrist. A sports bandage was used to hold the elec-
trodes in place, and impedance at the beginning was <10k ohms.
The sports bandage was routinely replaced after 5e6 sessions.
Neither of the participants reported burning sensations or discom-
fort during the stimulation. The studies from which these cases
were derived were approved by the ethics committee of University
College London and the University of Kent. Participants gave written
informed consent. The experimenter in all these sessionswas the se-
nior investigator, who had ample experience in tDCS.
Participant #1 e Only redness of the skin was observable post-
stimulation. After two days, the participant reported an itchy,
lumpy lesion (diameter ca. 8mm) on the dorsal side of her wrist,
in the electrode placement area. From day 4, the participant used
zinc oxide cream to promote healing. See Fig. 1a and b for images
taken on days 2 and 6. With the participant's permission, she wasd on day 18 and reported that the lesion was healing
was asked to send a photo, but she did not maintain
communication after this point.
Participant #2e Similarly to Participant #1, no signs of irritation
were observable following tDCS. After two days, Participant #2
developed a non-itchy, non-lumpy lesion (diameter ca. 6mm). In
this case, the lesion was located on the palmar side of the wrist,
while the electrode had been placed on the dorsal side. See
Fig.1ced for images taken on days 2 and 22. The participant wished
to take part in the second session, and the experimenter met with
the participant for evaluation on day 48. In the safety evaluation,
the participant still expressed a desire to participate in another ses-
sion, and as the risk to the participant was estimated as low and no
signs of skin irritationwere observable, the participant was granted
permission for a second session. The same stimulation protocol was
applied. The participant was checked for adverse effects on days 50
and 55, i.e., days 2 and 7 following the second session. No skin re-
actions were observed.
Since 2013, we have used the same stimulation protocol over
400 times, and these two incidents of skin lesions have been the
only observed cases. The participants had no history of such skin
changes, and we thus considered these lesions to be stimulation
induced. Previously, it has been suggested that the conditions of
the skineelectrode impedance (effective contact size and imped-
ance) are crucial in the formation of skin lesions [2]. While the
safety features of the stimulator prevent the stimulation from
continuing if the impedance rises too high, a decreased contact
area and/or an insufﬁciently moistened electrode cannot be ruled
out as causes for the ﬁrst participant's lesions.
However, while the second participant's lesion resembled the
other reported tDCS-induced lesions [3,4] in timing and appearance,
it did not form under the electrode. Although the lesion locationwas
very unusual, we consider this lesion to have been caused by saline
possibly having leaked out of the sponge, forming a conductive path
through the bandage to the palmar aspect of the wrist. Another pos-
sibility for these lesions is a pre-existing skin defect not apparent on
pre-stimulation examination. A small wound would provide a low-
resistance path through the skin, which would concentrate the cur-
rent in small area and could lead to injury [5].
Both delayed [6] and non-recurring [7] skin lesions have been
documented in association with tDCS. Issues such as using tap wa-
ter instead of saline, insufﬁciently moistened electrodes, electrode
shape, non-uniform pressure and individual skin properties have
been suggested as potential causes for these lesions, although the
causes for delayed reactions remain open. Nevertheless, we are
not aware of other reports of lesions on the opposite side of the
limb to the electrode location.
Fig. 1. Skin lesions of the two participants on different days following stimulation.
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guidelines, appear rare and manageable. Nonetheless, participants
should be informed of the possibility of their occurrence. In addi-
tion, care should be takenwhen administering saline to the sponge
electrodes. These two cases are may have followed the use of an
improper amount of saline; the ﬁrst participant may have received
an insufﬁcient amount, while the second participant's electrode
may have been excessively moistened. Similarly, the condition of
the electrodes should bemonitored, as in our experience, the absor-
bance characteristics of the electrodes changewith time, and harm-
ful substances may accumulate [6]. To account for the possibility of
pre-existing skin defects, the skin should be examined before stim-
ulation using adequate care and lighting.
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